Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF


Loncar Cancer Immunotherapy ETF (CNCR): $31.52

0.32 (+1.03%)

POWR Rating

Component Grades

Trade

NA

Buy & Hold

NA

Peer

NA

CNCR Stock Price Chart Interactive Chart >

Price chart for CNCR

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $31.52 52-week high $35.82
Prev. close $31.20 52-week low $12.00
Day low $31.04 Volume 3,100
Day high $31.75 Avg. volume 10,289
50-day MA $33.46 Dividend yield 0.91%
200-day MA $29.05

Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

CNCR ETF Info

Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 47.28M
Net Asset Value (NAV) $31.52
Options? Yes
Total Holdings 32

CNCR Price Returns

1-mo -3.99%
3-mo -1.35%
6-mo 21.49%
1-year 46.91%
3-year 6.78%
5-year 46.90%
YTD -0.62%
2020 36.53%
2019 24.22%
2018 -20.65%
2017 13.61%
2016 -25.63%

CNCR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNCR Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7453 seconds.